Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Japan Medical Dynamic Marketing, Inc. ( (JP:7600) ) has issued an announcement.
Japan Medical Dynamic Marketing, Inc. has revised its earnings forecasts for the second quarter and full fiscal year ending March 31, 2026, due to ongoing supply constraints affecting artificial knee joint products in the U.S. This has led to a temporary slowdown in surgeries in Japan and the U.S., impacting sales and profits. The company is addressing these challenges by optimizing its supply chain, reviewing staffing plans, and enhancing in-house manufacturing capabilities to improve profitability in the medium term. Despite the downward revision in earnings forecasts, the company plans to maintain its dividend payout, prioritizing stable profit distribution to shareholders.
The most recent analyst rating on (JP:7600) stock is a Hold with a Yen565.00 price target. To see the full list of analyst forecasts on Japan Medical Dynamic Marketing, Inc. stock, see the JP:7600 Stock Forecast page.
More about Japan Medical Dynamic Marketing, Inc.
Japan Medical Dynamic Marketing, Inc. operates in the medical industry, focusing on the distribution and marketing of medical devices, particularly artificial joint products. The company is engaged in both the Japanese and international markets, with a significant focus on the United States.
Average Trading Volume: 57,504
Technical Sentiment Signal: Strong Sell
Current Market Cap: Yen13.9B
Learn more about 7600 stock on TipRanks’ Stock Analysis page.